A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma

被引:2
|
作者
Zhang, Hai-Feng [1 ,2 ]
Delaidelli, Alberto [1 ,2 ]
Javed, Sumreen [3 ]
Turgu, Busra [1 ,2 ]
Morrison, Taylor [2 ]
Hughes, Christopher S. [1 ,2 ]
Yang, Xiaqiu [2 ]
Pachva, Manideep [1 ,2 ]
Lizardo, Michael M. [1 ,2 ]
Singh, Gurdeep [2 ]
Hoffmann, Jennifer [4 ,5 ]
Huang, Yue Zhou [2 ]
Patel, Khushbu [4 ,5 ,6 ]
Shraim, Rawan [4 ,5 ,7 ]
Kung, Sonia H. Y. [8 ]
Morin, Gregg B. [9 ,10 ]
Aparicio, Samuel [1 ,2 ]
Martinez, Daniel [4 ,5 ,6 ]
Maris, John M. [4 ,5 ,6 ]
Bosse, Kristopher R. [4 ,5 ,6 ]
Williams, Karla C. [3 ]
Sorensen, Poul H. [1 ,2 ]
机构
[1] Univ British Columbia, Dept Pathol & Lab Med, 2211 Wesbrook Mall, Vancouver, BC V6T 1Z4, Canada
[2] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada
[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[4] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[5] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[7] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA
[8] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada
[9] Canadas Michael Smith Genome Sci Ctr, Vancouver V5Z 4S6, BC, Canada
[10] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T1Z4, Canada
基金
加拿大健康研究院;
关键词
MIGRATION INHIBITORY FACTOR; DEAD BOX GENE; PLEIOTROPIC ROLE; GREB1; MEDULLOBLASTOMA; COAMPLIFICATION; EXPRESSION; MORPHOLOGY; REGULATOR; PROTEINS;
D O I
10.1126/sciadv.adg6693
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MYCN amplification (MNA) is a defining feature of high-risk neuroblastoma (NB) and predicts poor prognosis. However, whether genes within or in close proximity to the MYCN amplicon also contribute to MNA(+) NB remains poorly understood. Here, we identify that GREB1, a transcription factor encoding gene neighboring the MYCN locus, is frequently coexpressed with MYCN and promotes cell survival in MNA(+) NB. GREB1 controls gene expression independently of MYCN, among which we uncover myosin 1B (MYO1B) as being highly expressed in MNA(+) NB and, using a chick chorioallantoic membrane (CAM) model, as a crucial regulator of invasion and metastasis. Global secretome and proteome profiling further delineates MYO1B in regulating secretome reprogramming in MNA(+) NB cells, and the cytokine MIF as an important pro-invasive and pro-metastatic mediator of MYO1B activity. Together, we have identified a putative GREB1-MYO1B-MIF axis as an unconventional mechanism promoting aggressive behavior in MNA(+) NB and independently of MYCN.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathways
    Bojko, Jodie
    Kollareddy, Madhu
    Szemes, Marianna
    Bellamy, Jacob
    Poon, Evon
    Moukachar, Ahmad
    Legge, Danny
    Vincent, Emma E.
    Jones, Nicholas
    Malik, Sally
    Greenhough, Alexander
    Paterson, Alex
    Park, Ji Hyun
    Gallacher, Kelli
    Chesler, Louis
    Malik, Karim
    CANCER LETTERS, 2024, 604
  • [32] Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
    Buechner, J.
    Tomte, E.
    Haug, B. H.
    Henriksen, J. R.
    Lokke, C.
    Flaegstad, T.
    Einvik, C.
    BRITISH JOURNAL OF CANCER, 2011, 105 (02) : 296 - 303
  • [33] Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration
    Zaatiti, Hayat
    Abdallah, Jad
    Nasr, Zeina
    Khazen, George
    Sandler, Anthony
    Abou-Antoun, Tamara J.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (03) : 787 - 803
  • [34] Activation of cell migration via morphological changes in focal adhesions depends on shear stress in MYCN-amplified neuroblastoma cells
    Hiraiwa, Takumi
    Yamada, Takahiro G.
    Miki, Norihisa
    Funahashi, Akira
    Hiroi, Noriko
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2019, 16 (152)
  • [35] Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
    Abu-Zaid, Ahmed
    Fang, Jie
    Jin, Hongjian
    Singh, Shivendra
    Pichavaram, Prahalathan
    Wu, Qiong
    Tillman, Heather
    Janke, Laura
    Rosikiewicz, Wojciech
    Xu, Beisi
    Van De Velde, Lee -Ann
    Guo, Yian
    Li, Yimei
    Shendy, Noha A. M.
    Delahunty, Ian M.
    Rankovic, Zoran
    Chen, Taosheng
    Chen, Xiang
    Freeman, Kevin W.
    Hatley, Mark E.
    Durbin, Adam D.
    Murray, Peter J.
    Murphy, Andrew J.
    Thomas, Paul G.
    Davidoff, Andrew M.
    Yang, Jun
    CELL REPORTS MEDICINE, 2024, 5 (03)
  • [36] Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
    Lee, Eunjin
    Lee, Ji Won
    Lee, Boram
    Park, Kyunghee
    Shim, Joonho
    Yoo, Keon Hee
    Koo, Hong Hoe
    Sung, Ki Woong
    Park, Woong-Yang
    BMC MEDICAL GENOMICS, 2020, 13 (01)
  • [37] Heterogeneity of MYCN amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasis
    Marrano, Paula
    Irwin, Meredith S.
    Thorner, Paul S.
    GENES CHROMOSOMES & CANCER, 2017, 56 (01) : 28 - 41
  • [38] FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome
    Schmitt-Hoffner, Felix
    van Rijn, Sjoerd
    Toprak, Umut H.
    Mauermann, Monika
    Rosemann, Felix
    Heit-Mondrzyk, Anke
    Hubner, Jens-Martin
    Camgoz, Aylin
    Hartlieb, Sabine
    Pfister, Stefan M.
    Henrich, Kai-Oliver
    Westermann, Frank
    Kool, Marcel
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (29) : 3217 - +
  • [39] Burkholderia Lethal Factor 1, a Novel Anti-Cancer Toxin, Demonstrates Selective Cytotoxicity in MYCN-Amplified Neuroblastoma Cells
    Rust, Aleksander
    Shah, Sajid
    Hautbergue, Guillaume M.
    Davletov, Bazbek
    TOXINS, 2018, 10 (07):
  • [40] Impaired Antitumor Immune Response in MYCN-amplified Neuroblastoma Is Associated with Lack of CCL2 Secretion and Poor Dendritic Cell Recruitment
    Kacher, Jamila
    Manches, Olivier
    Aspord, Caroline
    Sartelet, Herve
    Chaperot, Laurence
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (07): : 577 - 589